Duke Cancer

@DukeCancer

Cancer creates its own rules. We recognized ending cancer requires a weapon as adaptable & multiform as the disease itself—Duke Cancer Institute.

Durham, NC

dukecancerinstitute.org

Joined September 2009

Replies Reposts Media

Duke Cancer
@DukeCancer
Aug 17
A new study led by DCI researchers offers important insights into that challenge in advanced prostate cancer and could help pave the way for more personalized treatment approaches in the future. duke.is/c/tbvz #ProstateCancer | @DukeMedSchool | @DukeHealth
1
Duke Cancer
@DukeCancer
Aug 4
Join us at Duke Rides for an indoor cycling relay benefiting DCI. Grab your team (4+ riders) and register today: duke.is/DukeRides Together we ride. Together we fight. 📆 Saturday, Oct. 3 ⏰ 12-5 p.m. 📍 Wilson Recreation Center, Durham, NC
Duke Cancer
@DukeCancer
Jul 29
DCI's Jung Wook Park, PhD, recently received a grant to investigate new molecular mechanisms that drive one of the most aggressive forms of prostate cancer and to identify potential therapeutic targets. duke.is/r/s5vc @DukePathDept | @DukeMedSchool
Dr. Jung Wook Park Receives NIH/NCI Grant to Advance New Therapeutic Targets for Aggressive...
From pathology.duke.edu
1
Duke Cancer
@DukeCancer
Jul 22
Radioligand therapies are approved to treat advanced prostate cancer and neuroendocrine tumors. DCI's Diane Reidy-Lagunes, MD, talks to Hannah McManus, MD, about the promises these therapies hold for the future. duke.is/v/fjtb @DukeHealth | @DukeGUCancer
00:00
Duke Cancer
@DukeCancer
Jul 21
DCI's Hui-Kuan Lin, PhD, received a grant from @theNCI to advance a promising strategy for targeting some of the most challenging cancers. duke.is/z/uepf @DukePathDept | @DukeMedSchool
NCI Funds Study Led by Dr. Hui-Kuan Lin Aiming to Unlock New Therapies for KRas-Driven Cancers
From pathology.duke.edu